跳至主要内容
临床试验/DRKS00033983
DRKS00033983已完成不适用

Perioperative antibiotic prophylaxis in patients with morbid obesity undergoing laparoscopic sleeve gastrectomy in a certified center of excellence for obesity and metabolic surgery

St. Josef KH Bad Driburg KHWE0 个研究点目标入组 525 人开始时间: 2024年4月8日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
525

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • The study included adult patients aged 18 and over with morbid obesity who underwent LSG in the Competence Center for Bariatric Surgery in Bad Driburg between January 1, 2018 and December 31, 2021 for the purpose of weight loss, regardless of gender, BMI and weight or obesity-related comorbidities.

排除标准

  • Patients who have already taken antibacterial substances for purposes other than PAP pre- or perioperatively or who stopped taking them more than 7 days preoperatively
  • Patients who have evidence of colonization with germs with known resistance to antibiotics (e.g. MRSA or MRGN)
  • Patients with immune deficiency
  • Patients in whom LSG was undertaken as a bariatric revision procedure (redo operations, e.g. gastric band removal with LSG).
  • Patients who have experienced other complications not related to surgical infection causing an increase in inflammatory parameters or antibiotic therapy and significantly alter the standardized course.

研究者

发起方
St. Josef KH Bad Driburg KHWE

相似试验